Diabetes pill shows Real-World promise for blood sugar and weight
NCT ID NCT05443334
Summary
This study observed how well the daily pill Rybelsus (oral semaglutide) worked for adults with type 2 diabetes in real-world Spanish clinics. Researchers tracked 465 patients for 8-10 months to see changes in blood sugar levels, body weight, and how satisfied people were with the treatment. The goal was to understand how this medication performs outside of strict clinical trials, in everyday medical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre for Spain
Barcelona, 08025, Spain
-
Master Centre for Spain
Madrid, 28033, Spain
Conditions
Explore the condition pages connected to this study.